POPS RICHARD F
SEC insider (Form 3/4/5 filer). CIK 0001126490. Director at NEUROCRINE BIOSCIENCES INC (NBIX) and 1 other issuer. 12 reported Form 4/5 transactions since Sep 2024; latest on May 27, 2026. Located in DUBLIN 4 IRELAND.
Companies POPS RICHARD F has filed insider reports for
- NEUROCRINE BIOSCIENCES INC (NBIX): Director
- Alkermes plc. (ALKS): Director, Officer, Director and CEO, Alkermes plc
POPS RICHARD F
CIK: 0001126490
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- May 27, 2026NBIX
NEUROCRINE BIOSCIENCES INC
AwardDirectRestriced Stock Unit
2.6K shares- - May 21, 2026NBIX
NEUROCRINE BIOSCIENCES INC
ExerciseDirect3.3K shares- - May 15, 2026NBIX
NEUROCRINE BIOSCIENCES INC
SaleDirect15K shares at avg. $157.65$2.4M - May 15, 2026NBIX
NEUROCRINE BIOSCIENCES INC
ExerciseDirect15K shares at avg. $47.89$718K - Mar 2, 2026ALKS
Alkermes plc.
AwardDirectRestricted Stock Unit Award
88.8K shares- - Feb 5, 2026ALKS
Alkermes plc.
AwardDirect149.6K shares- - Feb 5, 2026ALKS
Alkermes plc.
Tax PaymentDirect62.2K shares at avg. $33.55$2.1M - May 22, 2025NBIX
NEUROCRINE BIOSCIENCES INC
ExerciseDirect2.9K shares- - May 21, 2025NBIX
NEUROCRINE BIOSCIENCES INC
AwardDirectRestricted Stock Unit
3.3K shares- - Feb 19, 2025ALKS
Alkermes plc.
AwardDirectEmployee Stock Option (Right to Buy)
293.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 27, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Award Restriced Stock Unit | 2,567 | - | - | Direct |
| May 21, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise | 3,318 | - | $0 | Direct |
| May 15, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Sale | 15,000 | $157.65 | $2,364,761 | Direct |
| May 15, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise | 15,000 | $47.89 | $718,350 | Direct |
| Mar 2, 2026 | ALKS Alkermes plc. | Award Restricted Stock Unit Award | 88,843 | - | - | Direct |
| Feb 5, 2026 | ALKS Alkermes plc. | Award | 149,580 | - | $0 | Direct |
| Feb 5, 2026 | ALKS Alkermes plc. | Tax Payment | 62,230 | $33.55 | $2,087,816 | Direct |
| May 22, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise | 2,869 | - | - | Direct |
| May 21, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Award Restricted Stock Unit | 3,318 | - | - | Direct |
| Feb 19, 2025 | ALKS Alkermes plc. | Award Employee Stock Option (Right to Buy) | 293,921 | - | - | Direct |
1-10 of 12 transactions